Your browser doesn't support javascript.
loading
Prognostic and predictive role of gene mutations in chronic lymphocytic leukemia: results from the pivotal phase III study COMPLEMENT1.
Tausch, Eugen; Beck, Philipp; Schlenk, Richard F; Jebaraj, Billy J; Dolnik, Anna; Yosifov, Deyan Y; Hillmen, Peter; Offner, Fritz; Janssens, Ann; Babu, Govind K; Grosicki, Sebastian; Mayer, Jiri; Panagiotidis, Panagiotis; McKeown, Astrid; Gupta, Ira V; Skorupa, Alexandra; Pallaud, Celine; Bullinger, Lars; Mertens, Daniel; Döhner, Hartmut; Stilgenbauer, Stephan.
Afiliação
  • Tausch E; Department of Internal Medicine III, Ulm University, Ulm, Germany.
  • Beck P; Department of Internal Medicine III, Ulm University, Ulm, Germany.
  • Schlenk RF; Department of Internal Medicine III, Ulm University, Ulm, Germany.
  • Jebaraj BJ; Department of Internal Medicine III, Ulm University, Ulm, Germany.
  • Dolnik A; Klinik fur Innere Medizin fur Hematologie, Onkologie und Tumorimmunologie, Charité Berlin.
  • Yosifov DY; Department of Internal Medicine III, Ulm University, Ulm, Germany.
  • Hillmen P; Department of Haematology, St. James's University Hospital, Leeds, United Kingdom.
  • Offner F; Universitair Ziekenhuis Gent, Gent, Belgium.
  • Janssens A; Universitair Ziekenhuis Leuven, Leuven, Belgium.
  • Babu GK; Kidwai Memorial Institute of Oncology, Bangalore, India.
  • Grosicki S; Hematology and Cancer Prevention,School of Public Health,Silesian Medical University,Katowice,Poland.
  • Mayer J; Department of Haematology-Oncology, University Hospital Brno, Brno, Czech Republic.
  • Panagiotidis P; University of Athens, Laikon General Hospital, Athens, Greece.
  • McKeown A; Oncology Global Medicines Development, AstraZeneca, Melbourn, UK.
  • Gupta IV; GSK Oncology, GlaxoSmithKline, London, UK.
  • Skorupa A; Novartis Pharma GmbH, Nürnberg, Germany.
  • Pallaud C; Novartis AG, Basel, Switzerland.
  • Bullinger L; Klinik fur Innere Medizin fur Hematologie, Onkologie und Tumorimmunologie, Charité, Berlin.
  • Mertens D; Department of Internal Medicine III, Ulm University, Ulm, Germany.
  • Döhner H; Department of Internal Medicine III, Ulm University, Ulm, Germany.
  • Stilgenbauer S; Department of Internal Medicine III, Ulm University, Ulm, Germany.
Haematologica ; 105(10): 2440-2447, 2020 10 01.
Article em En | MEDLINE | ID: mdl-33054084
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Haematologica Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Haematologica Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Alemanha